New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
09:35 EDTAAPL, GG, NFLX, MU, TWTR, TSLA, AMZN, FB, AA, CELGActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AA FB AMZN TSLA TWTR MU NFLX GG CELG
News For AAPL;AA;FB;AMZN;TSLA;TWTR;MU;NFLX;GG;CELG From The Last 14 Days
Check below for free stories on AAPL;AA;FB;AMZN;TSLA;TWTR;MU;NFLX;GG;CELG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
August 19, 2014
11:18 EDTTSLAStocks with call strike movement; AEO TSLA
American Eagle (AEO) February 14 call option implied volatility decreased 2% to 39, Tesla (TSLA) December 285 call option implied volatility decreased 3% to 39 according to IVolatility.
09:38 EDTAAPL, CELG, FBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD TSLA CELG VLO VZ FB HD
08:27 EDTNFLXNetflix international opportunity larger than most realize, says MKM Partners
Subscribe for More Information
07:33 EDTCELGCelgene announces publication of REVLIMID combination results
Celgene announced that results of a study evaluating the combination of REVLIMID with rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone in untreated diffuse large b-cell lymphoma were published online ahead of print in the Journal of Clinical Oncology. In a phase II, open label, single arm study, 64 patients with newly diagnosed, untreated, stage II-IV CD20 positive DLBCL received 25 mg of lenalidomide on days 1-10 with standard dose R-CHOP every 21 days for six cycles. All patients received pegfilgrastim on day two of each cycle and aspirin prophylaxis throughout. The primary endpoint was event-free survival with secondary endpoints of progression free survival and overall survival. A one-stage binomial design was used to assess the efficacy and tolerability of REVLIMID with R-CHOP. Of the 64 patients enrolled, 60 were eligible for response evaluation. In these patients, the overall response rate was 98% with 80% achieving a complete response. The 24-month EFS, which was identical to PFS, and OS rates were 59% and 78%, respectively. The company said, "This study demonstrated that the addition of lenalidomide to conventional R-CHOP resulted in similar PFS rates and OS rates between sub-types. This is intriguing as patients with the non-GCB phenotype have traditionally experienced poorer outcomes. The results of this study support further evaluation of this regimen in this sub-type of DLBCL.
06:57 EDTAMZNAmazon.com implied volatility of 22 at lower end of index mean range
Subscribe for More Information
06:32 EDTAAPLMorgan Stanley recommends adding to Apple positions
Subscribe for More Information
06:10 EDTTWTRTwitter testing highlighting 'favorited' tweets, WSJ reports
Twitter is testing inserting tweets in some users' timelines that have been "favorited" by accounts they follow, an experiment which is receiving mixed reviews, the Wall Street Journal reports. Reference Link
August 18, 2014
16:00 EDTNFLX, AMZN, AAPL, TSLA, TWTROptions Update; August 18, 2014
Subscribe for More Information
09:35 EDTAMZN, AAPL, TSLA, FBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AMZN DG TSLA GILD FB ABX WFC C
09:20 EDTFBFacebook Q3 North American revenue tracking slightly above, says ITG Research
ITG Research said Facebook's Q3 North American revenue is tracking to $1.45B vs. consensus of $1.4B.
08:30 EDTAAPLApple starts production of smartphones with sapphire screens, Guardian says
Subscribe for More Information
08:13 EDTTSLATesla Motors volatility expected to move on CEO warns warranty change
Subscribe for More Information
07:58 EDTNFLXNetflix volatility at low end of historic range
Subscribe for More Information
07:58 EDTAAPLApple December quarter EPS likely to beat by 10%+, says RBC Capital
Subscribe for More Information
06:51 EDTTSLAElectric car production soared in China, Xinhua reports
Subscribe for More Information
06:47 EDTFBFacebook volatility at low end of historic range
Subscribe for More Information
06:42 EDTAAPLApple may call 5.5-inch iPhone '6L,' 9to5Mac reports
Apple may call its rumored 5.5-inch iPhone model the "6L," 9to5Mac reports, citing Asia-based rumor site Apple Daily. In this scenario, the 4.7-inch iPhone would be called the iPhone 6. Reference Link
05:23 EDTAAPLInvenSense downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded InvenSense (INVN) to Neutral citing valuation with shares near its $25 price target. Goldman also believes the near-term catalyst of share gains at Apple (AAPL) has passed. InvenSense closed Friday down 1c to $24.99.
August 17, 2014
18:38 EDTAAPLToo early to sell Apple, Barron's says
Subscribe for More Information
15:28 EDTTSLASaleen modified Tesla starts at $152K, Bloomberg says
Saleen Automotive, which modifies cars from their base chassis, is taking orders for a "tricked-out" Tesla model that starts at $152,000, says Bloomberg. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use